Document is current
Any future updates will be listed below
-
Authors
Toner, Yohana C.
Prévot, Geoffrey
van Leent, Mandy M. T.
Munitz, Jazz
Oosterwijk, Roderick
Verschuur, Anna Vera D.
van Elsas, Yuri
Peric, Vedran
Maas, Rianne J. F.
Ranzenigo, Anna
Morla-Folch, Judit
Wang, William
Umali, Martin
de Dreu, Anne
Fernandes, Jessica Chimene
Sullivan, Nathaniel A. T.
Maier, Alexander
Mason, Christian
Reiner, Thomas
Fayad, Zahi A.
Mulder, Willem J. M.
Teunissen, Abraham J. P.
Pérez-Medina, Carlos
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01 CA220234, R01 CA220234, R01 CA220234)
American Heart Association (16SDG31390007, 16SDG31390007)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek
European Research Council (101019807)
Ministerio de Ciencia e Innovación (PID2020-114902RB-I00 | AEI/10.13039/501100011033)
- License Information
-
More Information
Article History
Received: 5 September 2023
Accepted: 6 February 2024
First Online: 15 May 2024
Competing interests
: W.J.M.M. is a founder and CSO of Trained Therapeutix Discovery. Z.A.F. is a founder and member of the board of Trained Therapeutix Discovery. T.R. is now an employee of and shareholder in Novartis AG. No other potential financial or non-financial conflicts of interest relevant to this article exist.
